SAS and Carolina partner to accelerate antiviral drug development
Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI).
(UNC.edu)
Related: Campus Connections
Video: The Carolina Roots of Shibumi ShadesMeet the University of North Carolina alumni who created the Shibumi Shade, a popular wind-powered beach canopy that's now a fixture on about 800 beaches...
Mon Jun 16, 2025Look back at the Class of 2025’s 4 years at Carolina
As the University of North Carolina Clef Hangers serenaded Tar Heel graduates near the end of Spring Commencement with a rendition of James Taylor’s “Carolina...
Sun Jun 15, 2025
'Power of theater': UNC Department of Dramatic Art receives $2 million gift from alumna
University of North Carolina alumna Kathleen Ford has given a $2 million gift to the Department of Dramatic Art. The gift consists of a $1...
Fri Jun 13, 2025
Mexico defeats Turkey, 1-0, in international friendly soccer match at Kenan Stadium
Mexico’s men’s soccer national team defeated Turkey, 1-0, on Tuesday at Kenan Stadium in an international friendly soccer match as a part of the 2025...
Wed Jun 11, 2025
